Skip to main content
PredictPedia
MarketsWiki
K

FDA decision: Gedatolisib by Celcuity Inc. (July 2026)

77%
Trade
Event Group
EventKALSHI

FDA decision: Gedatolisib by Celcuity Inc. (July 2026)

FDA decision: Gedatolisib by Celcuity Inc. (July 2026)
Yes

77%

|
Vol

$0.00

|
Markets

5

Trade

Market Price Graph

5 markets tracked

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)

kalshi

No data available

All Markets(5)
MarketPrice
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)
77%
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Denied (CRL Issued))
10%
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Conditional / Accelerated Approval)
9%
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (No Decision)
7%
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Withdrawn by Sponsor)
3%

Markets (5)

Sort
KALSHIHealth
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)

If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is Full Approval before Aug 1, 2026, the market resolves to Yes. Early close condition: This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026

Health Score20/100
Yes Outcome76.5%
Yes
Volume$0.00
LiquidityN/A
End DateAug 08, 2026
View Details
KALSHIHealth
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Denied (CRL Issued))

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Denied (CRL Issued))

If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is Denied (CRL Issued) before Aug 1, 2026, the market resolves to Yes. Early close condition: This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026

Health Score20/100
Yes Outcome9.5%
Yes
Volume$0.00
LiquidityN/A
End DateAug 08, 2026
View Details
KALSHIHealth
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Conditional / Accelerated Approval)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Conditional / Accelerated Approval)

If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is Conditional / Accelerated Approval before Aug 1, 2026, the market resolves to Yes. Early close condition: This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026

Health Score20/100
Yes Outcome8.5%
Yes
Volume$0.00
LiquidityN/A
End DateAug 08, 2026
View Details
KALSHIHealth
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (No Decision)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (No Decision)

If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is No Decision before Aug 1, 2026, the market resolves to Yes. Early close condition: This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026

Health Score20/100
Yes Outcome6.5%
Yes
Volume$0.00
LiquidityN/A
End DateAug 08, 2026
View Details
KALSHIHealth
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Withdrawn by Sponsor)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Withdrawn by Sponsor)

If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is Withdrawn by Sponsor before Aug 1, 2026, the market resolves to Yes. Early close condition: This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026

Health Score20/100
Yes Outcome2.5%
Yes
Volume$0.00
LiquidityN/A
End DateAug 08, 2026
View Details

Share This Event

Share on social media or embed on your website

Back to Event Group